Search

Your search keyword '"Gaemperli O"' showing total 524 results
Start Over Author "Gaemperli O"
524 results on '"Gaemperli O"'

2. Procedural recommendations of cardiac PET/ CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation- (4Is) related cardiovascular diseases: a joint collaboration of the EACVI and the EANM: summary

Author

Slart, R, Glaudemans, A, Gheysens, O, Lubberink, M, Kero, T, Dweck, M, Habib, G, Gaemperli, O, Saraste, A, Gimelli, A, Georgoulias, P, Verberne, H, Bucerius, J, Rischpler, C, Hyafil, F, Erba, P, Slart R. H. J. A., Glaudemans A. W. J. M., Gheysens O., Lubberink M., Kero T., Dweck M. R., Habib G., Gaemperli O., Saraste A., Gimelli A., Georgoulias P., Verberne H. J., Bucerius J., Rischpler C., Hyafil F., Erba P. A., Slart, R, Glaudemans, A, Gheysens, O, Lubberink, M, Kero, T, Dweck, M, Habib, G, Gaemperli, O, Saraste, A, Gimelli, A, Georgoulias, P, Verberne, H, Bucerius, J, Rischpler, C, Hyafil, F, Erba, P, Slart R. H. J. A., Glaudemans A. W. J. M., Gheysens O., Lubberink M., Kero T., Dweck M. R., Habib G., Gaemperli O., Saraste A., Gimelli A., Georgoulias P., Verberne H. J., Bucerius J., Rischpler C., Hyafil F., and Erba P. A.

Abstract

With this summarized document we share the standard for positron emission tomography (PET)/(diagnostic)computed tomography (CT) imaging procedures in cardiovascular diseases that are inflammatory, infective, infiltrative, or associated with dysfunctional innervation (4Is) as recently published in the European Journal of Nuclear Medicine and Molecular Imaging. This standard should be applied in clinical practice and integrated in clinical (multicentre) trials for optimal standardization of the procedurals and interpretations. A major focus is put on procedures using [18F]-2-fluoro-2-deoxyglucose ([18F]FDG), but 4Is PET radiopharmaceuticals beyond [18F]FDG are also described in this summarized document. Whilst these novel tracers are currently mainly applied in early clinical trials, some multicentre trials are underway and we foresee in the near future their use in clinical care and inclusion in the clinical guidelines. Diagnosis and management of 4Is related cardiovascular diseases are generally complex and often require a multidisciplinary approach by a team of experts. The new standards described herein should be applied when using PET/CT and PET/magnetic resonance, within a multimodality imaging framework both in clinical practice and in clinical trials for 4Is cardiovascular indications.

Published
2021

3. Position paper of the EACVI and EANM on artificial intelligence applications in multimodality cardiovascular imaging using SPECT/CT, PET/CT, and cardiac CT

Author

Slart, R, Williams, M, Juarez-Orozco, L, Rischpler, C, Dweck, M, Glaudemans, A, Gimelli, A, Georgoulias, P, Gheysens, O, Gaemperli, O, Habib, G, Hustinx, R, Cosyns, B, Verberne, H, Hyafil, F, Erba, P, Lubberink, M, Slomka, P, Isgum, I, Visvikis, D, Kolossvary, M, Saraste, A, Slart R. H. J. A., Williams M. C., Juarez-Orozco L. E., Rischpler C., Dweck M. R., Glaudemans A. W. J. M., Gimelli A., Georgoulias P., Gheysens O., Gaemperli O., Habib G., Hustinx R., Cosyns B., Verberne H. J., Hyafil F., Erba P. A., Lubberink M., Slomka P., Isgum I., Visvikis D., Kolossvary M., Saraste A., Slart, R, Williams, M, Juarez-Orozco, L, Rischpler, C, Dweck, M, Glaudemans, A, Gimelli, A, Georgoulias, P, Gheysens, O, Gaemperli, O, Habib, G, Hustinx, R, Cosyns, B, Verberne, H, Hyafil, F, Erba, P, Lubberink, M, Slomka, P, Isgum, I, Visvikis, D, Kolossvary, M, Saraste, A, Slart R. H. J. A., Williams M. C., Juarez-Orozco L. E., Rischpler C., Dweck M. R., Glaudemans A. W. J. M., Gimelli A., Georgoulias P., Gheysens O., Gaemperli O., Habib G., Hustinx R., Cosyns B., Verberne H. J., Hyafil F., Erba P. A., Lubberink M., Slomka P., Isgum I., Visvikis D., Kolossvary M., and Saraste A.

Abstract

In daily clinical practice, clinicians integrate available data to ascertain the diagnostic and prognostic probability of a disease or clinical outcome for their patients. For patients with suspected or known cardiovascular disease, several anatomical and functional imaging techniques are commonly performed to aid this endeavor, including coronary computed tomography angiography (CCTA) and nuclear cardiology imaging. Continuous improvement in positron emission tomography (PET), single-photon emission computed tomography (SPECT), and CT hardware and software has resulted in improved diagnostic performance and wide implementation of these imaging techniques in daily clinical practice. However, the human ability to interpret, quantify, and integrate these data sets is limited. The identification of novel markers and application of machine learning (ML) algorithms, including deep learning (DL) to cardiovascular imaging techniques will further improve diagnosis and prognostication for patients with cardiovascular diseases. The goal of this position paper of the European Association of Nuclear Medicine (EANM) and the European Association of Cardiovascular Imaging (EACVI) is to provide an overview of the general concepts behind modern machine learning-based artificial intelligence, highlights currently prefered methods, practices, and computational models, and proposes new strategies to support the clinical application of ML in the field of cardiovascular imaging using nuclear cardiology (hybrid) and CT techniques.

Published
2021

4. Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation (4Is)-related cardiovascular diseases: a joint collaboration of the EACVI and the EANM

Author

Slart, R, Glaudemans, A, Gheysens, O, Lubberink, M, Kero, T, Dweck, M, Habib, G, Gaemperli, O, Saraste, A, Gimelli, A, Georgoulias, P, Verberne, H, Bucerius, J, Rischpler, C, Hyafil, F, Erba, P, Slart R. H. J. A., Glaudemans A. W. J. M., Gheysens O., Lubberink M., Kero T., Dweck M. R., Habib G., Gaemperli O., Saraste A., Gimelli A., Georgoulias P., Verberne H. J., Bucerius J., Rischpler C., Hyafil F., Erba P. A., Slart, R, Glaudemans, A, Gheysens, O, Lubberink, M, Kero, T, Dweck, M, Habib, G, Gaemperli, O, Saraste, A, Gimelli, A, Georgoulias, P, Verberne, H, Bucerius, J, Rischpler, C, Hyafil, F, Erba, P, Slart R. H. J. A., Glaudemans A. W. J. M., Gheysens O., Lubberink M., Kero T., Dweck M. R., Habib G., Gaemperli O., Saraste A., Gimelli A., Georgoulias P., Verberne H. J., Bucerius J., Rischpler C., Hyafil F., and Erba P. A.

Abstract

With this document, we provide a standard for PET/(diagnostic) CT imaging procedures in cardiovascular diseases that are inflammatory, infective, infiltrative, or associated with dysfunctional innervation (4Is). This standard should be applied in clinical practice and integrated in clinical (multicenter) trials for optimal procedural standardization. A major focus is put on procedures using [18F]FDG, but 4Is PET radiopharmaceuticals beyond [18F]FDG are also described in this document. Whilst these novel tracers are currently mainly applied in early clinical trials, some multicenter trials are underway and we foresee in the near future their use in clinical care and inclusion in the clinical guidelines. Finally, PET/MR applications in 4Is cardiovascular diseases are also briefly described. Diagnosis and management of 4Is-related cardiovascular diseases are generally complex and often require a multidisciplinary approach by a team of experts. The new standards described herein should be applied when using PET/CT and PET/MR, within a multimodality imaging framework both in clinical practice and in clinical trials for 4Is cardiovascular indications.

Published
2021

5. Coronary computed tomography angiography-derived endothelial shear stress in myocardial bridging

Author

Giannopoulos, A., primary, Bolt, B., additional, Benz, D., additional, Messerli, M., additional, Schwyzer, M., additional, Von Felten, E., additional, Kamani, C., additional, Patriki, D., additional, Gebhard, C., additional, Pazhenkottil, A., additional, Graeni, C., additional, Kaufmann, P., additional, Buechel, R.R., additional, and Gaemperli, O., additional

Published
2022
Full Text
View/download PDF

6. Implanted cardiac devices and how to recognize them on CT

Author

Gaemperli, Oliver, et al, Gaemperli, O ( Oliver ), et al, ( ), Benz, Dominik C, Gaemperli, Oliver, et al, Gaemperli, O ( Oliver ), et al, ( ), and Benz, Dominik C

Abstract

Implanted cardiac devices are more commonly encountered in patients undergoing cardiac CT—either to assess the device itself or for various other cardiac or extracardiac indications (e.g. coronary CT angiography, left atrial anatomical map for radiofrequency ablations, and CT pulmonary angiography). Therefore, it is paramount for the cardiovascular imager to recognize the devices and be familiar with the normal findings. Meanwhile, patients with implanted devices may pose challenges to CT imaging, including beam hardening and partial volume effects, and motion artefacts from a rapid and irregular heart rate. Therefore, imaging protocols should be optimized for image quality. This chapter will present the most common implanted cardiac devices. They range from valvular devices to rhythm-management devices like pacemakers or implantable cardioverter defibrillators, occluders of the left atrial appendage, persistent foramen ovale, or septal defects to circulatory assist devices. Moreover, the chapter will address the most common complications associated with these devices one should be aware of.

Published
2022

7. Cardiomyopathies

Author

Gaemperli, Oliver, et al, Gaemperli, O ( Oliver ), et al, ( ), Benz, Dominik C, Gaemperli, Oliver, et al, Gaemperli, O ( Oliver ), et al, ( ), and Benz, Dominik C

Abstract

Cardiomyopathies are defined as a myocardial disorder with a structurally and functionally abnormal heart muscle in the absence of coronary artery disease, valvular disease, hypertension, and congenital heart disease. Based on morphological and functional phenotypes, and according to the 2008 European Society of Cardiology classification of cardiomyopathies, these are grouped into hypertrophic cardiomyopathy, dilated cardiomyopathy, arrhythmogenic cardiomyopathy, restrictive cardiomyopathy, and unclassified cardiomyopathies. In addition, each cardiomyopathy is subclassified into familial and non-familial forms. CT may be a useful alternative to echocardiography and cardiac magnetic resonance imaging in the diagnosis of cardiomyopathies. Important CT findings include myocardial tissue abnormalities, abnormal ejection fraction and volumes, exclusion of underlying coronary or valvular disease, and abnormal myocardial perfusion/myocardial fibrosis

Published
2022

8. Patient selection and preparation

Author

Gaemperli, Oliver, et al, Gaemperli, O ( Oliver ), et al, ( ), Rajani, Ronak, Károlyi, Mihály, Gaemperli, Oliver, et al, Gaemperli, O ( Oliver ), et al, ( ), Rajani, Ronak, and Károlyi, Mihály

Abstract

Since the introduction of computed tomography (CT) this technology has evolved at a breath-taking pace to become a cornerstone of non-invasive imaging in clinical practice. Supported by further technological refinements, clinical trial evidence, and guideline recommendations, cardiac CT and, foremost, coronary CT angiography, has been embraced as an indispensable non-invasive cardiac imaging modality and an important first-line test for coronary artery disease. Recently, the potential of cardiac CT has become evident for the diagnosis and guidance of treatment in a variety of other cardiac pathologies beyond coronary artery disease, including valvular disease, atrial fibrillation and other arrhythmias, endocarditis, cardiac masses, cardiomyopathies, and others.

Published
2022

9. Contributors

Author

Anagnostopoulos, C.D., primary, Badano, L.P., additional, Baksi, A.J., additional, Bekkers, S.C.A.M., additional, Bischoff, B., additional, Bissell, M.M., additional, Braun, D., additional, Budde, R.P.J., additional, Buechel, R.R., additional, Camilleri, S., additional, Cappeliez, O., additional, Chow, B.J.W., additional, Coenen, A., additional, Cosyns, B., additional, Crean, A.M., additional, Dijkshoorn, M., additional, Donal, E., additional, Edvardsen, T., additional, Fernández-Golfín, C., additional, Ferreira, V.M., additional, Flotats, A., additional, Gaemperli, O., additional, Galderisi, M., additional, Galli, E., additional, Gaubert, J.-Y., additional, Gerber, B.L., additional, Gimelli, A., additional, Goetschalckx, K., additional, Greenwood, J.P., additional, Gurunathan, S., additional, Habets, J., additional, Habib, G., additional, Hasselberg, N.E., additional, Hausleiter, J., additional, Karamitsos, T.D., additional, Kaufmann, P.A., additional, Kietselaer, B.L., additional, Knaapen, P., additional, Lancellotti, P., additional, Lederlin, M., additional, Leeson, P., additional, Leiner, T., additional, Lombardi, M., additional, Lubberink, M., additional, Ludman, A.J., additional, Magalhães, T.A., additional, Mahjoub, H., additional, Mahnken, A., additional, Manrique, A., additional, Marra, M.P., additional, Motwani, M., additional, Muraru, D., additional, Neubauer, S., additional, Nieman, K., additional, Paelinck, B., additional, Pasquet, A.A., additional, Pennell, D.J., additional, Petersen, S.E., additional, Pibarot, P., additional, Pison, L., additional, Plein, S., additional, Polsani, V., additional, Premaratne, M., additional, Pugliese, F., additional, Rademakers, F.E., additional, Robson, M.D., additional, Rochitte, C.E., additional, Salgado, R., additional, Schulz-Menger, J., additional, Senior, R., additional, Singh, P., additional, Tawakol, A., additional, Tyler, D.J., additional, Vannan, M., additional, Wassmuth, R., additional, Zamorano, J., additional, and Zhou, X., additional

Published
2015
Full Text
View/download PDF

12. Multimodality imaging in the diagnosis, risk stratification, and management of patients with dilated cardiomyopathies: An expert consensus document from the European Association of Cardiovascular Imaging

Author

Donal, E, Delgado, V, Bucciarelli-Ducci, C, Galli, E, Haugaa, K, Charron, P, Voigt, J, Cardim, N, Masci, P, Galderisi, M, Gaemperli, O, Gimelli, A, Pinto, Y, Lancellotti, P, Habib, G, Elliott, P, Edvardsen, T, Cosyns, B, Popescu, B, Gerber, B, Muraru, D, Flachskampf, F, Plein, S, Neglia, D, Cameli, M, Weytjens, C, Donal E., Delgado V., Bucciarelli-Ducci C., Galli E., Haugaa K. H., Charron P., Voigt J. -U., Cardim N., Masci P. G., Galderisi M., Gaemperli O., Gimelli A., Pinto Y. M., Lancellotti P., Habib G., Elliott P., Edvardsen T., Cosyns B., Popescu B. A., Gerber B., Muraru D., Flachskampf F., Plein S., Neglia D., Cameli M., Weytjens C., Donal, E, Delgado, V, Bucciarelli-Ducci, C, Galli, E, Haugaa, K, Charron, P, Voigt, J, Cardim, N, Masci, P, Galderisi, M, Gaemperli, O, Gimelli, A, Pinto, Y, Lancellotti, P, Habib, G, Elliott, P, Edvardsen, T, Cosyns, B, Popescu, B, Gerber, B, Muraru, D, Flachskampf, F, Plein, S, Neglia, D, Cameli, M, Weytjens, C, Donal E., Delgado V., Bucciarelli-Ducci C., Galli E., Haugaa K. H., Charron P., Voigt J. -U., Cardim N., Masci P. G., Galderisi M., Gaemperli O., Gimelli A., Pinto Y. M., Lancellotti P., Habib G., Elliott P., Edvardsen T., Cosyns B., Popescu B. A., Gerber B., Muraru D., Flachskampf F., Plein S., Neglia D., Cameli M., and Weytjens C.

Abstract

Dilated cardiomyopathy (DCM) is defined by the presence of left ventricular or biventricular dilatation and systolic dysfunction in the absence of abnormal loading conditions or coronary artery disease sufficient to explain these changes. This is a heterogeneous disease frequently having a genetic background. Imaging is important for the diagnosis, the prognostic assessment and for guiding therapy. A multimodality imaging approach provides a comprehensive evaluation of all the issues related to this disease. The present document aims to provide recommendations for the use of multimodality imaging according to the clinical question. Selection of one or another imaging technique should be based on the clinical condition and context. Techniques are presented with the aim to underscore what is 'clinically relevant' and what are the tools that 'can be used'. There remain some gaps in evidence on the impact of multimodality imaging on the management and the treatment of DCM patients where ongoing research is important.

Published
2019

13. Wytyczne ESC/ESH dotyczace postȩpowania w nadciśnieniu tȩtniczym (2018): Grupa Robocza Europejskiego Towarzystwa Kardiologicznego (ESC) i Europejskiego Towarzystwa Nadciśnienia Tȩtniczego (ESH) do spraw postȩpowania w nadciśnieniu tȩtniczym

Author

Williams, B, Mancia, G, Spiering, W, Rosei, E, Azizi, M, Burnier, M, Clement, D, Coca, A, De Simone, G, Dominiczak, A, Kahan, T, Mahfoud, F, Redon, J, Ruilope, L, Zanchetti, A, Kerins, M, Kjeldsen, S, Kreutz, R, Laurent, S, Lip, G, Mcmanus, R, Narkiewicz, K, Ruschitzka, F, Schmieder, R, Shlyakhto, E, Tsioufis, C, Aboyans, V, Desormais, I, Windecker, S, Agewall, S, Barbato, E, Bueno, H, Collet, J, Coman, I, Dean, V, Delgado, V, Fitzsimons, D, Gaemperli, O, Hindricks, G, Iung, B, Juni, P, Katus, H, Knuuti, J, Lancellotti, P, Leclercq, C, Mcdonagh, T, Piepoli, M, Ponikowski, P, Richter, D, Roffi, M, Simpson, I, Sousa-Uva, M, Zamorano, J, Lurbe, E, Bochud, M, Jelakovic, B, Januszewicz, A, Polonia, J, Van De Borne, P, Borghi, C, Parati, G, Manolis, A, Lovic, D, Benkhedda, S, Zelveian, P, Siostrzonek, P, Najafov, R, Pavlova, O, De Pauw, M, Dizdarevic-Hudic, L, Raev, D, Karpettas, N, Olsen, M, Shaker, A, Viigimaa, M, Baranova, E, Metsarinne, K, Halimi, J, Pagava, Z, Thomopoulos, C, Bertomeu-Martinez, V, Wittekoek, J, Andersen, K, Shechter, M, Romanova, T, Bajraktari, G, Saade, G, Sakalyte, G, Noppe, S, Trusinskis, K, Vavlukis, M, Demarco, D, Caraus, A, Schunkert, H, Aksnes, T, Jankowski, P, Linhart, A, Vinereanu, D, Foscoli, M, Dikic, A, Filipova, S, Fras, Z, Burkard, T, Carlberg, B, Sdiri, W, Aydogdu, S, Sirenko, Y, Pall, D, Brady, A, Mercuro, G, Weber, T, Lazareva, I, De Backer, T, Sokolovic, S, Chazova, I, Porsti, I, Denolle, T, Stergiou, G, Segura, J, Miglinas, M, Kramer, B, Gerdts, E, Tykarski, A, De Carvalho Rodrigues, M, Widimsky, J, Dorobantu, M, Brguljan, J, Pechere-Bertschi, A, Gottsater, A, Erdine, S, Williams B., Mancia G., Spiering W., Rosei E. A., Azizi M., Burnier M., Clement D. L., Coca A., De Simone G., Dominiczak A., Kahan T., Mahfoud F., Redon J., Ruilope L., Zanchetti A., Kerins M., Kjeldsen S. E., Kreutz R., Laurent S., Lip G. Y. H., McManus R., Narkiewicz K., Ruschitzka F., Schmieder R. E., Shlyakhto E., Tsioufis C., Aboyans V., Desormais I., Windecker S., Agewall S., Barbato E., Bueno H., Collet J. -P., Coman I. M., Dean V., Delgado V., Fitzsimons D., Gaemperli O., Hindricks G., Iung B., Juni P., Katus H. A., Knuuti J., Lancellotti P., Leclercq C., McDonagh T. A., Piepoli M. F., Ponikowski P., Richter D. J., Roffi M., Simpson I. A., Sousa-Uva M., Zamorano J. L., Lurbe E., Bochud M., Jelakovic B., Januszewicz A., Polonia J., Van De Borne P., Borghi C., Parati G., Manolis A., Lovic D., Benkhedda S., Zelveian P., Siostrzonek P., Najafov R., Pavlova O., De Pauw M., Dizdarevic-Hudic L., Raev D., Karpettas N., Olsen M. H., Shaker A. F., Viigimaa M., Baranova E. I., Metsarinne K., Halimi J. -M., Pagava Z., Thomopoulos C., Bertomeu-Martinez V., Wittekoek J., Andersen K., Shechter M., Romanova T., Bajraktari G., Saade G. A., Sakalyte G., Noppe S., Trusinskis K., Vavlukis M., DeMarco D. C., Caraus A., Schunkert H., Aksnes T. A., Jankowski P., Linhart A., Vinereanu D., Foscoli M., Dikic A. D., Filipova S., Fras Z., Burkard T., Carlberg B., Sdiri W., Aydogdu S., Sirenko Y., Pall D., Brady A., Mercuro G., Weber T., Lazareva I., De Backer T., Sokolovic S., Chazova I., Porsti I., Denolle T., Stergiou G. S., Segura J., Miglinas M., Kramer B. K., Gerdts E., Tykarski A., De Carvalho Rodrigues M., Widimsky J., Dorobantu M., Brguljan J., Pechere-Bertschi A., Gottsater A., Erdine S., Williams, B, Mancia, G, Spiering, W, Rosei, E, Azizi, M, Burnier, M, Clement, D, Coca, A, De Simone, G, Dominiczak, A, Kahan, T, Mahfoud, F, Redon, J, Ruilope, L, Zanchetti, A, Kerins, M, Kjeldsen, S, Kreutz, R, Laurent, S, Lip, G, Mcmanus, R, Narkiewicz, K, Ruschitzka, F, Schmieder, R, Shlyakhto, E, Tsioufis, C, Aboyans, V, Desormais, I, Windecker, S, Agewall, S, Barbato, E, Bueno, H, Collet, J, Coman, I, Dean, V, Delgado, V, Fitzsimons, D, Gaemperli, O, Hindricks, G, Iung, B, Juni, P, Katus, H, Knuuti, J, Lancellotti, P, Leclercq, C, Mcdonagh, T, Piepoli, M, Ponikowski, P, Richter, D, Roffi, M, Simpson, I, Sousa-Uva, M, Zamorano, J, Lurbe, E, Bochud, M, Jelakovic, B, Januszewicz, A, Polonia, J, Van De Borne, P, Borghi, C, Parati, G, Manolis, A, Lovic, D, Benkhedda, S, Zelveian, P, Siostrzonek, P, Najafov, R, Pavlova, O, De Pauw, M, Dizdarevic-Hudic, L, Raev, D, Karpettas, N, Olsen, M, Shaker, A, Viigimaa, M, Baranova, E, Metsarinne, K, Halimi, J, Pagava, Z, Thomopoulos, C, Bertomeu-Martinez, V, Wittekoek, J, Andersen, K, Shechter, M, Romanova, T, Bajraktari, G, Saade, G, Sakalyte, G, Noppe, S, Trusinskis, K, Vavlukis, M, Demarco, D, Caraus, A, Schunkert, H, Aksnes, T, Jankowski, P, Linhart, A, Vinereanu, D, Foscoli, M, Dikic, A, Filipova, S, Fras, Z, Burkard, T, Carlberg, B, Sdiri, W, Aydogdu, S, Sirenko, Y, Pall, D, Brady, A, Mercuro, G, Weber, T, Lazareva, I, De Backer, T, Sokolovic, S, Chazova, I, Porsti, I, Denolle, T, Stergiou, G, Segura, J, Miglinas, M, Kramer, B, Gerdts, E, Tykarski, A, De Carvalho Rodrigues, M, Widimsky, J, Dorobantu, M, Brguljan, J, Pechere-Bertschi, A, Gottsater, A, Erdine, S, Williams B., Mancia G., Spiering W., Rosei E. A., Azizi M., Burnier M., Clement D. L., Coca A., De Simone G., Dominiczak A., Kahan T., Mahfoud F., Redon J., Ruilope L., Zanchetti A., Kerins M., Kjeldsen S. E., Kreutz R., Laurent S., Lip G. Y. H., McManus R., Narkiewicz K., Ruschitzka F., Schmieder R. E., Shlyakhto E., Tsioufis C., Aboyans V., Desormais I., Windecker S., Agewall S., Barbato E., Bueno H., Collet J. -P., Coman I. M., Dean V., Delgado V., Fitzsimons D., Gaemperli O., Hindricks G., Iung B., Juni P., Katus H. A., Knuuti J., Lancellotti P., Leclercq C., McDonagh T. A., Piepoli M. F., Ponikowski P., Richter D. J., Roffi M., Simpson I. A., Sousa-Uva M., Zamorano J. L., Lurbe E., Bochud M., Jelakovic B., Januszewicz A., Polonia J., Van De Borne P., Borghi C., Parati G., Manolis A., Lovic D., Benkhedda S., Zelveian P., Siostrzonek P., Najafov R., Pavlova O., De Pauw M., Dizdarevic-Hudic L., Raev D., Karpettas N., Olsen M. H., Shaker A. F., Viigimaa M., Baranova E. I., Metsarinne K., Halimi J. -M., Pagava Z., Thomopoulos C., Bertomeu-Martinez V., Wittekoek J., Andersen K., Shechter M., Romanova T., Bajraktari G., Saade G. A., Sakalyte G., Noppe S., Trusinskis K., Vavlukis M., DeMarco D. C., Caraus A., Schunkert H., Aksnes T. A., Jankowski P., Linhart A., Vinereanu D., Foscoli M., Dikic A. D., Filipova S., Fras Z., Burkard T., Carlberg B., Sdiri W., Aydogdu S., Sirenko Y., Pall D., Brady A., Mercuro G., Weber T., Lazareva I., De Backer T., Sokolovic S., Chazova I., Porsti I., Denolle T., Stergiou G. S., Segura J., Miglinas M., Kramer B. K., Gerdts E., Tykarski A., De Carvalho Rodrigues M., Widimsky J., Dorobantu M., Brguljan J., Pechere-Bertschi A., Gottsater A., and Erdine S.

Published
2019

14. Multimodality imaging in the diagnosis, risk stratification, and management of patients with dilated cardiomyopathies: an expert consensus document from the European Association of Cardiovascular Imaging

Author

Donal E., Delgado V., Bucciarelli-Ducci C., Galli E., Haugaa K. H., Charron P., Voigt J. -U., Cardim N., Masci P. G., Galderisi M., Gaemperli O., Gimelli A., Pinto Y. M., Lancellotti P., Habib G., Elliott P., Edvardsen T., Cosyns B., Popescu B. A., Gerber B., Muraru D., Flachskampf F., Plein S., Neglia D., Cameli M., Weytjens C., Laboratoire Traitement du Signal et de l'Image (LTSI), Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Pontchaillou [Rennes], University of Bristol [Bristol], Centre d'Investigation Clinique [Rennes] (CIC), Université de Rennes (UR)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM), Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Research Unit on Cardiovascular and Metabolic Diseases (ICAN), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Institut de Cardiométabolisme et Nutrition = Institute of Cardiometabolism and Nutrition [CHU Pitié Salpêtrière] (IHU ICAN), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-CHU Pitié-Salpêtrière [AP-HP], Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Hôpital Ambroise Paré [AP-HP], Catholic University of Leuven - Katholieke Universiteit Leuven (KU Leuven), University of Amsterdam [Amsterdam] (UvA), Hôpital de la Timone [CHU - APHM] (TIMONE), Microbes évolution phylogénie et infections (MEPHI), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), University College of London [London] (UCL), Université de Médecine Carol Davila, National Institute on Handicapped Research, NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research, Bristol National Institute of Health Research, BRC, Clinical sciences, Cardio-vascular diseases, Cardiology, Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris-Sud - Paris 11 (UP11)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Versailles Saint-Quentin-en-Yvelines (UVSQ), Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Institute of cardiometabolism and nutrition (ICAN), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), ACS - Heart failure & arrhythmias, Donal, E., Delgado, V., Bucciarelli-Ducci, C., Galli, E., Haugaa, K. H., Charron, P., Voigt, J. -U., Cardim, N., Masci, P. G., Galderisi, M., Gaemperli, O., Gimelli, A., Pinto, Y. M., Lancellotti, P., Habib, G., Elliott, P., Edvardsen, T., Cosyns, B., Popescu, B. A., Gerber, B., Muraru, D., Flachskampf, F., Plein, S., Neglia, D., Cameli, M., Weytjens, C., CHU Pitié-Salpêtrière [APHP], Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Research Unit on Cardiovascular and Metabolic Diseases [IHU ICAN], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Pitié-Salpêtrière [AP-HP], Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES), Donal, E, Delgado, V, Bucciarelli-Ducci, C, Galli, E, Haugaa, K, Charron, P, Voigt, J, Cardim, N, Masci, P, Galderisi, M, Gaemperli, O, Gimelli, A, Pinto, Y, Lancellotti, P, Habib, G, Elliott, P, Edvardsen, T, Cosyns, B, Popescu, B, Gerber, B, Muraru, D, Flachskampf, F, Plein, S, Neglia, D, Cameli, M, and Weytjens, C

Subjects
Cardiac & Cardiovascular Systems, Disease, 030204 cardiovascular system & hematology, Multimodal Imaging, Coronary artery disease, 0302 clinical medicine, echocardiography, Cardiac magnetic resonance, Dilated cardiomyopathy, Echocardiography, Nuclear imaging, Prognosis, Treatment, 030212 general & internal medicine, EACVI/ASE/INDUSTRY TASK-FORCE, nuclear imaging, CARDIAC-RESYNCHRONIZATION THERAPY, treatment, Radiology, Nuclear Medicine & Medical Imaging, LATE GADOLINIUM ENHANCEMENT, Dilated cardiomyopathy, General Medicine, 3. Good health, Risk stratification, [SDV.IB]Life Sciences [q-bio]/Bioengineering, Cardiology and Cardiovascular Medicine, Life Sciences & Biomedicine, NATIVE VALVULAR REGURGITATION, Cardiomyopathy, Dilated, medicine.medical_specialty, Consensus, Prognosi, Context (language use), CARDIOLOGY WORKING GROUP, Risk Assessment, cardiac magnetic resonance, GLOBAL LONGITUDINAL STRAIN, Multimodality, 03 medical and health sciences, SPECKLE TRACKING ECHOCARDIOGRAPHY, medicine, Medical imaging, Humans, Radiology, Nuclear Medicine and imaging, Intensive care medicine, Science & Technology, business.industry, Expert consensus, LONG-TERM SURVIVAL, medicine.disease, SECONDARY MITRAL REGURGITATION, dilated cardiomyopathy, LEFT-VENTRICULAR DYSSYNCHRONY, Cardiovascular System & Cardiology, prognosis, business
Abstract

Dilated cardiomyopathy (DCM) is defined by the presence of left ventricular or biventricular dilatation and systolic dysfunction in the absence of abnormal loading conditions or coronary artery disease sufficient to explain these changes. This is a heterogeneous disease frequently having a genetic background. Imaging is important for the diagnosis, the prognostic assessment and for guiding therapy. A multimodality imaging approach provides a comprehensive evaluation of all the issues related to this disease. The present document aims to provide recommendations for the use of multimodality imaging according to the clinical question. Selection of one or another imaging technique should be based on the clinical condition and context. Techniques are presented with the aim to underscore what is 'clinically relevant' and what are the tools that 'can be used'. There remain some gaps in evidence on the impact of multimodality imaging on the management and the treatment of DCM patients where ongoing research is important. ispartof: EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING vol:20 issue:10 pages:1075-1093 ispartof: location:England status: published

Published
2019

15. Impact of mitral regurgitation aetiology on MitraClip outcomes: the MitraSwiss registry

Author

Surder D, Klersy C, Corti R, Biasco L, Gaemperli O, Maisano F, Toggweiler S, Jeger R, Naegeli B, Noble S, Biaggi P, Moccetti T, Pedrazzini G, Collaborators, Surder, D, Klersy, C, Corti, R, Biasco, L, Gaemperli, O, Maisano, F, Toggweiler, S, Jeger, R, Naegeli, B, Noble, S, Biaggi, P, Moccetti, T, Pedrazzini, G, and Collaborators

Published
2020

16. Acute and midterm outcomes of the post-approval MELODY Registry: a multicentre registry of transcatheter pulmonary valve implantation

Author

Nordmeyer, J., Ewert, P., Gewillig, M., AlJufan, M., Carminati, M., Kretschmar, O., Uebing, A., Dahnert, I., Rohle, R., Schneider, H., Witsenburg, M., Benson, L., Gitter, R., Bokenkamp, R., Mahadevan, V., Berger, F., Aggoun, Y., Agnoletti, G., Baumgartner, H., Lezo, J.S. de, Sofia, R., Dessy, H., Wolf, D. de, Dittrich, S., Dohlen, G., Emmel, M., Emmertsen, K., Fichtlscherer, S., Gabriel, H., Gaemperli, O., Gamillscheg, A., Godart, F., Guerin, P., Hofbeck, M., Marti, G., Michel-Behnke, I., Milanesi, O., Pinto, F., Qureshi, S., Schranz, D., Sievert, H., Sinisalo, J.P., Sluysmans, T., Spadoni, I., MELODY Registry Investigators, Pediatrics, University of Zurich, and Nordmeyer, Johannes

Subjects
Adult, Male, medicine.medical_specialty, Cardiac Catheterization, Time Factors, Heart disease, Adolescent, Heart Valve Diseases, 610 Medicine & health, 030204 cardiovascular system & hematology, 2705 Cardiology and Cardiovascular Medicine, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Interquartile range, Internal medicine, medicine, Humans, Transcatheter pulmonary valve implantation, 030212 general & internal medicine, Registries, Child, Retrospective Studies, Congenital heart disease, Heart Valve Prosthesis Implantation, Pulmonary Valve, Surrogate endpoint, business.industry, Hazard ratio, RVOT dysfunction, medicine.disease, Confidence interval, medicine.anatomical_structure, Treatment Outcome, Ventricle, 10036 Medical Clinic, Infective endocarditis, Cohort, Cardiology, Female, Cardiology and Cardiovascular Medicine, business, Follow-Up Studies
Abstract

Aims The post-approval MELODY Registry aimed to obtain multicentre registry data after transcatheter pulmonary valve implantation (TPVI) with the Melody™ valve (Medtronic plc.) in a large-scale cohort of patients with congenital heart disease (CHD). Methods and results Retrospective analysis of multicentre registry data after TPVI with the Melody™ valve. Eight hundred and forty-five patients (mean age: 21.0 ± 11.1 years) underwent TPVI in 42 centres between December 2006 and September 2013 and were followed-up for a median of 5.9 years (range: 0–11.0 years). The composite endpoint of TPVI-related events during follow-up (i.e. death, reoperation, or reintervention >48 h after TPVI) showed an incidence rate of 4.2% per person per year [95% confidence interval (CI) 3.7–4.9]. Transcatheter pulmonary valve implantation infective endocarditis (I.E.) showed an incidence rate of 2.3% per person per year (95% CI 1.9–2.8) and resulted in significant morbidity and in nine deaths. In multivariable Cox proportional hazard models, the invasively measured residual right ventricle (RV)-to-pulmonary artery (PA) pressure gradient (per 5 mmHg) was associated with the risk of the composite endpoint (adjusted hazard ratio: 1.21, 95% CI 1.12–1.30; P 2 improved significantly from 36 [interquartile range (IQR) 24–47] to 12 (IQR 7–17) mmHg and 47 to 1%, respectively (P Conclusion The post-approval MELODY Registry confirms the efficacy of TPVI with the Melody™ valve in a large-scale cohort of CHD patients. The residual invasively measured RV-to-PA pressure gradient may serve as a target for further improvement in the composite endpoint and TPVI I.E. However, TPVI I.E. remains a significant concern causing significant morbidity and mortality.

Published
2019

18. Wytyczne ESC/ESH dotyczace postȩpowania w nadciśnieniu tȩtniczym (2018): Grupa Robocza Europejskiego Towarzystwa Kardiologicznego (ESC) i Europejskiego Towarzystwa Nadciśnienia Tȩtniczego (ESH) do spraw postȩpowania w nadciśnieniu tȩtniczym

Author

Williams B., Mancia G., Spiering W., Rosei E. A., Azizi M., Burnier M., Clement D. L., Coca A., De Simone G., Dominiczak A., Kahan T., Mahfoud F., Redon J., Ruilope L., Zanchetti A., Kerins M., Kjeldsen S. E., Kreutz R., Laurent S., Lip G. Y. H., McManus R., Narkiewicz K., Ruschitzka F., Schmieder R. E., Shlyakhto E., Tsioufis C., Aboyans V., Desormais I., Windecker S., Agewall S., Barbato E., Bueno H., Collet J. -P., Coman I. M., Dean V., Delgado V., Fitzsimons D., Gaemperli O., Hindricks G., Iung B., Juni P., Katus H. A., Knuuti J., Lancellotti P., Leclercq C., McDonagh T. A., Piepoli M. F., Ponikowski P., Richter D. J., Roffi M., Simpson I. A., Sousa-Uva M., Zamorano J. L., Lurbe E., Bochud M., Jelakovic B., Januszewicz A., Polonia J., Van De Borne P., Borghi C., Parati G., Manolis A., Lovic D., Benkhedda S., Zelveian P., Siostrzonek P., Najafov R., Pavlova O., De Pauw M., Dizdarevic-Hudic L., Raev D., Karpettas N., Olsen M. H., Shaker A. F., Viigimaa M., Baranova E. I., Metsarinne K., Halimi J. -M., Pagava Z., Thomopoulos C., Bertomeu-Martinez V., Wittekoek J., Andersen K., Shechter M., Romanova T., Bajraktari G., Saade G. A., Sakalyte G., Noppe S., Trusinskis K., Vavlukis M., DeMarco D. C., Caraus A., Schunkert H., Aksnes T. A., Jankowski P., Linhart A., Vinereanu D., Foscoli M., Dikic A. D., Filipova S., Fras Z., Burkard T., Carlberg B., Sdiri W., Aydogdu S., Sirenko Y., Pall D., Brady A., Mercuro G., Weber T., Lazareva I., De Backer T., Sokolovic S., Chazova I., Porsti I., Denolle T., Stergiou G. S., Segura J., Miglinas M., Kramer B. K., Gerdts E., Tykarski A., De Carvalho Rodrigues M., Widimsky J., Dorobantu M., Brguljan J., Pechere-Bertschi A., Gottsater A., Erdine S., Williams, B, Mancia, G, Spiering, W, Rosei, E, Azizi, M, Burnier, M, Clement, D, Coca, A, De Simone, G, Dominiczak, A, Kahan, T, Mahfoud, F, Redon, J, Ruilope, L, Zanchetti, A, Kerins, M, Kjeldsen, S, Kreutz, R, Laurent, S, Lip, G, Mcmanus, R, Narkiewicz, K, Ruschitzka, F, Schmieder, R, Shlyakhto, E, Tsioufis, C, Aboyans, V, Desormais, I, Windecker, S, Agewall, S, Barbato, E, Bueno, H, Collet, J, Coman, I, Dean, V, Delgado, V, Fitzsimons, D, Gaemperli, O, Hindricks, G, Iung, B, Juni, P, Katus, H, Knuuti, J, Lancellotti, P, Leclercq, C, Mcdonagh, T, Piepoli, M, Ponikowski, P, Richter, D, Roffi, M, Simpson, I, Sousa-Uva, M, Zamorano, J, Lurbe, E, Bochud, M, Jelakovic, B, Januszewicz, A, Polonia, J, Van De Borne, P, Borghi, C, Parati, G, Manolis, A, Lovic, D, Benkhedda, S, Zelveian, P, Siostrzonek, P, Najafov, R, Pavlova, O, De Pauw, M, Dizdarevic-Hudic, L, Raev, D, Karpettas, N, Olsen, M, Shaker, A, Viigimaa, M, Baranova, E, Metsarinne, K, Halimi, J, Pagava, Z, Thomopoulos, C, Bertomeu-Martinez, V, Wittekoek, J, Andersen, K, Shechter, M, Romanova, T, Bajraktari, G, Saade, G, Sakalyte, G, Noppe, S, Trusinskis, K, Vavlukis, M, Demarco, D, Caraus, A, Schunkert, H, Aksnes, T, Jankowski, P, Linhart, A, Vinereanu, D, Foscoli, M, Dikic, A, Filipova, S, Fras, Z, Burkard, T, Carlberg, B, Sdiri, W, Aydogdu, S, Sirenko, Y, Pall, D, Brady, A, Mercuro, G, Weber, T, Lazareva, I, De Backer, T, Sokolovic, S, Chazova, I, Porsti, I, Denolle, T, Stergiou, G, Segura, J, Miglinas, M, Kramer, B, Gerdts, E, Tykarski, A, De Carvalho Rodrigues, M, Widimsky, J, Dorobantu, M, Brguljan, J, Pechere-Bertschi, A, Gottsater, A, and Erdine, S

Subjects
Antihypertensive Agent, Cardiology, Disease Management
Published
2019

21. Recommendations on nuclear and multimodality imaging in IE and CIED infections

Author

Erba, P, Lancellotti, P, Vilacosta, I, Gaemperli, O, Rouzet, F, Hacker, M, Signore, A, Slart, R, Habib, G, Erba P. A., Lancellotti P., Vilacosta I., Gaemperli O., Rouzet F., Hacker M., Signore A., Slart R. H. J. A., Habib G., Erba, P, Lancellotti, P, Vilacosta, I, Gaemperli, O, Rouzet, F, Hacker, M, Signore, A, Slart, R, Habib, G, Erba P. A., Lancellotti P., Vilacosta I., Gaemperli O., Rouzet F., Hacker M., Signore A., Slart R. H. J. A., and Habib G.

Abstract

In the latest update of the European Society of Cardiology (ESC) guidelines for the management of infective endocarditis (IE), imaging is positioned at the centre of the diagnostic work-up so that an early and accurate diagnosis can be reached. Besides echocardiography, contrast-enhanced CT (ce-CT), radiolabelled leucocyte (white blood cell, WBC) SPECT/CT and [18F]FDG PET/CT are included as diagnostic tools in the diagnostic flow chart for IE. Following the clinical guidelines that provided a straightforward message on the role of multimodality imaging, we believe that it is highly relevant to produce specific recommendations on nuclear multimodality imaging in IE and cardiac implantable electronic device infections. In these procedural recommendations we therefore describe in detail the technical and practical aspects of WBC SPECT/CT and [18F]FDG PET/CT, including ce-CT acquisition protocols. We also discuss the advantages and limitations of each procedure, specific pitfalls when interpreting images, and the most important results from the literature, and also provide recommendations on the appropriate use of multimodality imaging.

Published
2018

22. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies

Author

Celutkiene, J., Pudil, R., Lopez-Fernandez, T., Grapsa, J., Nihoyannopoulos, P., Bergler-Klein, J., Cohen-Solal, A., Farmakis, D., Tocchetti, C. G., Haehling, S., Barberis, V., Flachskampf, F. A., Ceponlene, J., Haegler-Laube, E., Suter, T., Lapinskas, T., Prasad, S., Boer, R. A., Wechalekar, K., Anker, M. S., Iakobishvili, Z., Bucciarelli-Ducci, C., Schulz-Menger, J., Cosyns, B., Gaemperli, O., Belenkov, Y., Hulot, J-S, Galderisi, M., Lancellotti, P., Bax, J., Marwick, T. H., Chioncel, O., Jaarsma, T., Mullens, W., Piepoli, M., Thum, T., Heymans, S., Mueller, C., Moura, B., Ruschitzka, F., Zamorano, J. L., Rosano, G., Coats, A. J. S., Asteggiano, R., Seferovic, P., Thor Edvardsen, Lyon, A. R., Cardiovascular Centre (CVC), Hulot, Jean-Sebastien/0000-0001-5463-6117, Edvardsen, Thor/0000-0002-3800-765X, Bucciarelli-Ducci, Chiara/0000-0002-2515-0852, Clinical sciences, Cardio-vascular diseases, Cardiology, Cardiologie, MUMC+: MA Med Staf Spec Cardiologie (9), and RS: Carim - H02 Cardiomyopathy

Subjects
Vascular Endothelial Growth Factor A, Global longitudinal strain, SPECKLE-TRACKING ECHOCARDIOGRAPHY, Cardiac magnetic resonance, Cardiology, Antineoplastic Agents, Heart failure, ANTHRACYCLINE CARDIOTOXICITY, Imaging, LEFT-VENTRICULAR FUNCTION, Neoplasms, MAGNETIC-RESONANCE, BREAST-CANCER, Humans, AMERICAN SOCIETY, Computed tomography, Cardiotoxicity, MYOCARDIAL STRAIN, DIASTOLIC FUNCTION, Cardio-oncology, Radiology Nuclear Medicine and imaging, Echocardiography, oncology, Female, CHAMBER QUANTIFICATION, Cardiology and Cardiovascular Medicine, Nuclear imaging
Abstract

Cardiovascular (CV) imaging is an important tool in baseline risk assessment and detection of CV disease in oncology patients receiving cardiotoxic cancer therapies. This position statement examines the role of echocardiography, cardiac magnetic resonance, nuclear cardiac imaging and computed tomography in the management of cancer patients. The Imaging and Cardio-Oncology Study Groups of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) in collaboration with the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the ESC have evaluated the current evidence for the value of modern CV imaging in the cardio-oncology field. The most relevant echocardiographic parameters, including global longitudinal strain and three-dimensional ejection fraction, are proposed. The protocol for baseline pre-treatment evaluation and specific surveillance algorithms or pathways for anthracycline chemotherapy, HER2-targeted therapies such as trastuzumab, vascular endothelial growth factor tyrosine kinase inhibitors, BCr-Abl tyrosine kinase inhibitors, proteasome inhibitors and immune checkpoint inhibitors are presented. The indications for CV imaging after completion of oncology treatment are considered. The typical consequences of radiation therapy and the possibility of their identification in the long term are also summarized. Special populations are discussed including female survivors planning pregnancy, patients with carcinoid disease, patients with cardiac tumours and patients with right heart failure. Future directions and ongoing CV imaging research in cardio-oncology are discussed. R.A.d.B. is supported by the Netherlands Heart Foundation (CVON DOSIS, grant 2014-40, CVON SHE-PREDICTS-HF, grant 2017-21, and CVON RED-CVD, grant 2017-11), and the European Research Council (ERC CoG 818715, SECRETE-HF). C.G.T. is supported by a Federico II University/Ricerca di Ateneo grant. Celutkiene, J (corresponding author), Vilnius Univ, Fac Med, Inst Clin Med, Clin Cardiac & Vasc Dis, Santariskiu 2, LT-08661 Vilnius, Lithuania. jelena.celutkiene@santa.lt

Published
2020

23. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)

Author

Celutkiene, J, Pudil, R, Lopez-Fernandez, T, Grapsa, J, Nihoyannopoulos, P, Bergler-Klein, J, Cohen-Solal, A, Farmakis, D, Tocchetti, CG, von Haehling, S, Barberis, V, Flachskampf, FA, Ceponiene, I, Haegler-Laube, E, Suter, T, Lapinskas, T, Prasad, S, de Boer, RA, Wechalekar, K, Anker, MS, Iakobishvili, Z, Bucciarelli-Ducci, C, Schulz-Menger, J, Cosyns, B, Gaemperli, O, Belenkov, Y, Hulot, J-S, Galderisi, M, Lancellotti, P, Bax, J, Marwick, TH, Chioncel, O, Jaarsma, T, Mullens, W, Piepoli, M, Thum, T, Heymans, S, Mueller, C, Moura, B, Ruschitzka, F, Zamorano, JL, Rosano, G, Coats, AJS, Asteggiano, R, Seferovic, P, Edvardsen, T, Lyon, AR, Celutkiene, J, Pudil, R, Lopez-Fernandez, T, Grapsa, J, Nihoyannopoulos, P, Bergler-Klein, J, Cohen-Solal, A, Farmakis, D, Tocchetti, CG, von Haehling, S, Barberis, V, Flachskampf, FA, Ceponiene, I, Haegler-Laube, E, Suter, T, Lapinskas, T, Prasad, S, de Boer, RA, Wechalekar, K, Anker, MS, Iakobishvili, Z, Bucciarelli-Ducci, C, Schulz-Menger, J, Cosyns, B, Gaemperli, O, Belenkov, Y, Hulot, J-S, Galderisi, M, Lancellotti, P, Bax, J, Marwick, TH, Chioncel, O, Jaarsma, T, Mullens, W, Piepoli, M, Thum, T, Heymans, S, Mueller, C, Moura, B, Ruschitzka, F, Zamorano, JL, Rosano, G, Coats, AJS, Asteggiano, R, Seferovic, P, Edvardsen, T, and Lyon, AR

Abstract

Cardiovascular (CV) imaging is an important tool in baseline risk assessment and detection of CV disease in oncology patients receiving cardiotoxic cancer therapies. This position statement examines the role of echocardiography, cardiac magnetic resonance, nuclear cardiac imaging and computed tomography in the management of cancer patients. The Imaging and Cardio-Oncology Study Groups of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) in collaboration with the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the ESC have evaluated the current evidence for the value of modern CV imaging in the cardio-oncology field. The most relevant echocardiographic parameters, including global longitudinal strain and three-dimensional ejection fraction, are proposed. The protocol for baseline pre-treatment evaluation and specific surveillance algorithms or pathways for anthracycline chemotherapy, HER2-targeted therapies such as trastuzumab, vascular endothelial growth factor tyrosine kinase inhibitors, BCr-Abl tyrosine kinase inhibitors, proteasome inhibitors and immune checkpoint inhibitors are presented. The indications for CV imaging after completion of oncology treatment are considered. The typical consequences of radiation therapy and the possibility of their identification in the long term are also summarized. Special populations are discussed including female survivors planning pregnancy, patients with carcinoid disease, patients with cardiac tumours and patients with right heart failure. Future directions and ongoing CV imaging research in cardio-oncology are discussed.

Published
2020

25. Poster session: Dobutamine stress echo

Author

Biaggi, P, Felix, C, Gruner, C, Hohlfeld, S, Herzog, B, Gaemperli, O, Gruenenfelder, J, Corti, R, Tanner, FC, and Bettex, D

Published
2012

26. 2017 ESC update on dual antiplatelet therapy in coronary disease developed in collaboration with the EACTS

Author

Valgimigli A. D. G. D. T. M., Bueno H., Byrne R. A., Collet J. -P., Costa F., Jeppsson A., Juni P., Kastrati A., Kolh P., Mauri L., Montalescot G., Neumann F. -J., Petricevic M., Roffi M., Steg P. G., Windecker S., Zamorano J. L., Levine C. A. G. N., Badimon R. D. D. L., Vranckx P., Agewall S., Andreotti F., Antman E., Barbato E., Bassand J. -P., Bugiardini R., Cikirikcioglu M., Cuisset T., De Bonis M., Delgado V., Fitzsimons D., Gaemperli O., Galie N., Gilard M., Hamm C. W., Ibanez B., Iung B., James S., Knuuti J., Landmesser U., Leclercq C., Lettino M., Lip G., Piepoli M. F., Pierard L., Schwerzmann M., Sechtem U., Simpson I. A., Uva M. S., Stabile E., Storey R. F., Tendera M., Van de Werf F., Verheugt F., Aboyans V., Valgimigli, A. D. G. D. T. M., Bueno, H., Byrne, R. A., Collet, J. -P., Costa, F., Jeppsson, A., Juni, P., Kastrati, A., Kolh, P., Mauri, L., Montalescot, G., Neumann, F. -J., Petricevic, M., Roffi, M., Steg, P. G., Windecker, S., Zamorano, J. L., Levine, C. A. G. N., Badimon, R. D. D. L., Vranckx, P., Agewall, S., Andreotti, F., Antman, E., Barbato, E., Bassand, J. -P., Bugiardini, R., Cikirikcioglu, M., Cuisset, T., De Bonis, M., Delgado, V., Fitzsimons, D., Gaemperli, O., Galie, N., Gilard, M., Hamm, C. W., Ibanez, B., Iung, B., James, S., Knuuti, J., Landmesser, U., Leclercq, C., Lettino, M., Lip, G., Piepoli, M. F., Pierard, L., Schwerzmann, M., Sechtem, U., Simpson, I. A., Uva, M. S., Stabile, E., Storey, R. F., Tendera, M., Van de Werf, F., Verheugt, F., and Aboyans, V.

Published
2018

27. Multimodality Imaging in Restrictive Cardiomyopathies: An EACVI expert consensus document In collaboration with the 'Working Group on myocardial and pericardial diseases' of the European Society of Cardiology Endorsed by The Indian Academy of Echocardiography

Author

Habib, G, Bucciarelli-Ducci, C, Caforio, A, Cardim, N, Charron, P, Cosyns, B, Dehaene, A, Derumeaux, G, Donal, E, Dweck, M, Edvardsen, T, Erba, P, Ernande, L, Gaemperli, O, Galderisi, M, Grapsa, J, Jacquier, A, Klingel, K, Lancellotti, P, Neglia, D, Pepe, A, Perrone-Filardi, P, Petersen, S, Plein, S, Popescu, B, Reant, P, Sade, L, Salaun, E, Slart, R, Tribouilloy, C, Zamorano, J, Delgado, V, Haugaa, K, Vijayaraghavan, G, Habib G., Bucciarelli-Ducci C., Caforio A. L. P., Cardim N., Charron P., Cosyns B., Dehaene A., Derumeaux G., Donal E., Dweck M. R., Edvardsen T., Erba P. A., Ernande L., Gaemperli O., Galderisi M., Grapsa J., Jacquier A., Klingel K., Lancellotti P., Neglia D., Pepe A., Perrone-Filardi P., Petersen S. E., Plein S., Popescu B. A., Reant P., Sade L. E., Salaun E., Slart R. H. J. A., Tribouilloy C., Zamorano J., Delgado V., Haugaa K., Vijayaraghavan G., Habib, G, Bucciarelli-Ducci, C, Caforio, A, Cardim, N, Charron, P, Cosyns, B, Dehaene, A, Derumeaux, G, Donal, E, Dweck, M, Edvardsen, T, Erba, P, Ernande, L, Gaemperli, O, Galderisi, M, Grapsa, J, Jacquier, A, Klingel, K, Lancellotti, P, Neglia, D, Pepe, A, Perrone-Filardi, P, Petersen, S, Plein, S, Popescu, B, Reant, P, Sade, L, Salaun, E, Slart, R, Tribouilloy, C, Zamorano, J, Delgado, V, Haugaa, K, Vijayaraghavan, G, Habib G., Bucciarelli-Ducci C., Caforio A. L. P., Cardim N., Charron P., Cosyns B., Dehaene A., Derumeaux G., Donal E., Dweck M. R., Edvardsen T., Erba P. A., Ernande L., Gaemperli O., Galderisi M., Grapsa J., Jacquier A., Klingel K., Lancellotti P., Neglia D., Pepe A., Perrone-Filardi P., Petersen S. E., Plein S., Popescu B. A., Reant P., Sade L. E., Salaun E., Slart R. H. J. A., Tribouilloy C., Zamorano J., Delgado V., Haugaa K., and Vijayaraghavan G.

Abstract

Restrictive cardiomyopathies (RCMs) are a diverse group of myocardial diseases with a wide range of aetiologies, including familial, genetic and acquired diseases and ranging from very rare to relatively frequent cardiac disorders. In all these diseases, imaging techniques play a central role. Advanced imaging techniques provide important novel data on the diagnostic and prognostic assessment of RCMs. This EACVI consensus document provides comprehensive information for the appropriateness of all non-invasive imaging techniques for the diagnosis, prognostic evaluation, and management of patients with RCM.

Published
2017

28. Comprehensive multi-modality imaging approach in arrhythmogenic cardiomyopathy - an expert consensus document of the European Association of Cardiovascular Imaging

Author

Haugaa, K, Basso, C, Badano, L, Bucciarelli-Ducci, C, Cardim, N, Gaemperli, O, Galderisi, M, Habib, G, Knuuti, J, Lancellotti, P, Mckenna, W, Neglia, D, Popescu, B, Edvardsen, T, Haugaa K. H., Basso C., Badano L., Bucciarelli-Ducci C., Cardim N., Gaemperli O., Galderisi M., Habib G., Knuuti J., Lancellotti P., Mckenna W., Neglia D., Popescu B. A., Edvardsen T., Haugaa, K, Basso, C, Badano, L, Bucciarelli-Ducci, C, Cardim, N, Gaemperli, O, Galderisi, M, Habib, G, Knuuti, J, Lancellotti, P, Mckenna, W, Neglia, D, Popescu, B, Edvardsen, T, Haugaa K. H., Basso C., Badano L., Bucciarelli-Ducci C., Cardim N., Gaemperli O., Galderisi M., Habib G., Knuuti J., Lancellotti P., Mckenna W., Neglia D., Popescu B. A., and Edvardsen T.

Abstract

Arrhythmogenic cardiomyopathy (AC) is a progressive disease with high risk of life-threatening ventricular arrhythmias. A genetic mutation is found in up to 50-60% of probands, mostly affecting desmosomal genes. Diagnosis of AC is made by a combination of data from different modalities including imaging, electrocardiogram, Holter monitoring, family history, genetic testing, and tissue properties. Being a progressive cardiomyopathy, repeated cardiac imaging is needed in AC patients. Repeated imaging is important also for risk assessment of ventricular arrhythmias. This expert consensus document gives clinical recommendations for how to use multi-modality imaging in the different aspects of AC disease, including diagnosis, family screening, follow-up, risk assessment, and differential diagnosis. Published on behalf of the European Society of Cardiology. All rights reserved.

Published
2017

32. Cost-effectiveness analysis of stand-alone or combined non-invasive imaging tests for the diagnosis of stable coronary artery disease: results from the EVINCI study

Author

Lorenzoni, V., Bellelli, S., Caselli, C., Knuuti, J., Underwood, S.R., Neglia, D., Turchetti, G., Pietila, M., M?ki, M., Teresinska, A., Aguad?-Bruix, S., Pizzi, M.N., Todiere, G., Gimelli, A., Lombardi, M., Puzzuoli, S., Mangione, M., Marcheschi, P., Schroeder, S., Drosch, T., Poddighe, R., Casolo, G., Anagnostopoulos, C., Pugliese, F., Rouzet, F., Guludec, D. le, Cappelli, F., Valente, S., Gensini, G.F., Zawaideh, C., Capitanio, S., Sambuceti, G., Marsico, F., Filardi, P.P., Fern?ndez-Golf?n, C., Rinc?n, L.M., Zamorano, J.L., Graner, F.P., Nekolla, S., Graaf, M.A. de, Scholte, A.J.H.A., Fiechter, M., Stehli, J., Gaemperli, O., Kaufmann, P.A., Reyes, E., Nkomo, S., Carpeggiani, C., Giannessi, D., Mariani, F., Marinelli, M., Sicari, R., and EVINCI Investigators

Subjects
medicine.medical_specialty, Noninvasive imaging, Cost effectiveness, Economics, Econometrics and Finance (miscellaneous), Economic, Angiography, Coronary artery disease, Coronary computed tomography, Cost-effectiveness, Invasive coronary angiography, Stress-imaging, Health care management, Stress imaging, 03 medical and health sciences, 0302 clinical medicine, medicine, 030212 general & internal medicine, GeneralLiterature_REFERENCE(e.g.,dictionaries,encyclopedias,glossaries), Original Paper, medicine.diagnostic_test, I18, business.industry, 030503 health policy & services, Health Policy, I12, Cost-effectiveness analysis, medicine.disease, 3. Good health, ddc, Radiology, 0305 other medical science, business
Abstract

Aim This study aimed at evaluating the cost-effectiveness of different non-invasive imaging-guided strategies for the diagnosis of obstructive coronary artery disease (CAD) in a European population of patients from the Evaluation of Integrated Cardiac Imaging in Ischemic Heart Disease (EVINCI) study. Methods and results Cost-effectiveness analysis was performed in 350 patients (209 males, mean age 59 ± 9 years) with symptoms of suspected stable CAD undergoing computed tomography coronary angiography (CTCA) and at least one cardiac imaging stress-test prior to invasive coronary angiography (ICA) and in whom imaging exams were analysed at dedicated core laboratories. Stand-alone stress-tests or combined non-invasive strategies, when the first exam was uncertain, were compared. The diagnostic end-point was obstructive CAD defined as > 50% stenosis at quantitative ICA in the left main or at least one major coronary vessel. Effectiveness was defined as the percentage of correct diagnosis (cd) and costs were calculated using country-specific reimbursements. Incremental cost-effectiveness ratios (ICERs) were obtained using per-patient data and considering “no-imaging” as reference. The overall prevalence of obstructive CAD was 28%. Strategies combining CTCA followed by stress ECHO, SPECT, PET, or stress CMR followed by CTCA, were all cost-effective. ICERs values indicated cost saving from − 969€/cd for CMR-CTCA to − 1490€/cd for CTCA-PET, − 3092€/cd for CTCA-SPECT and − 3776€/cd for CTCA-ECHO. Similarly when considering early revascularization as effectiveness measure. Conclusion In patients with suspected stable CAD and low prevalence of disease, combined non-invasive strategies with CTCA and stress-imaging are cost-effective as gatekeepers to ICA and to select candidates for early revascularization. Electronic supplementary material The online version of this article (10.1007/s10198-019-01096-5) contains supplementary material, which is available to authorized users.

Published
2019

33. Characterization of functionally significant coronary artery disease by a coronary computed tomography angiography-based index: A comparison with positron emission tomography

Author

Anagnostopoulos, C.D. Siogkas, P.K. Liga, R. Benetos, G. Maaniitty, T. Sakellarios, A.I. Koutagiar, I. Karakitsios, I. Papafaklis, M.I. Berti, V. Sciagrà, R. Scholte, A.J.H.A. Michalis, L.K. Gaemperli, O. Kaufmann, P.A. Pelosi, G. Parodi, O. Knuuti, J. Fotiadis, D.I. Neglia, D.

Abstract

To test the hypothesis that virtual functional assessment index (vFAI) is related with regional flow parameters derived by quantitative positron emission tomography (PET) and can be used to assess abnormal vasodilating capability in coronary vessels with stenotic lesions at coronary computed tomography angiography (CCTA). Methods and results: vFAI, stress myocardial blood flow (MBF), and myocardial flow reserve (MFR) were assessed in 78 patients (mean age 62.2 ± 7.7 years) with intermediate pre-test likelihood of coronary artery disease (CAD). Coronary stenoses ≥50% were considered angiographically significant. PET was considered positive for significant CAD, when more than one contiguous segments showed stress MBF ≤2.3 mL/g/min for O-water or

Published
2019

34. 2018 ESC/ESH Guidelines for the management of arterial

Author

Williams B, Mancia G, Spiering W, Rosei E, Azizi M, Burnier M, Clement D, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen S, Kreutz R, Laurent S, Lip G, McManus R, Narkiewicz K, Ruschitzka F, Schmieder R, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I, Windecker S, Agewall S, Barbato E, Bueno H, Collet J, Coman I, Dean V, Delgado V, Fitzsimons D, Gaemperli O, Hindricks G, Iung B, Juni P, Katus H, Knuuti J, Lancellotti P, Leclercq C, McDonagh T, Piepoli M, Ponikowski P, Richter D, Roffi M, Simpson I, Sousa-Uva M, Zamorano J, Lurbe E, Bochud M, Jelakovic B, Januszewicz A, Polonia J, van de Borne P, Borghi C, Parati G, Manolis A, Lovic D, Grp Robocza Europejskiego Towarzys, and Europejskiego Towarzystwa Nadcisni

Published
2019

35. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy

Author

Regitz-Zagrosek, V, Roos-Hesselink, JW, Bauersachs, J, Blomström-Lundqvist, C, Cífková, R, De Bonis, M, Iung, B, Johnson, MR, Kintscher, U, Kranke, P, Lang, IM, Morais, J, Pieper, PG, Presbitero, P, Price, S, Rosano, GMC, Seeland, U, Simoncini, T, Swan, L, Warnes, CA, Deaton, C, Simpson, IA, Aboyans, V, Agewall, S, Barbato, E, Calda, P, Coca, A, Coman, IM, De Backer, J, Delgado, V, Di Salvo, G, Fitzsimmons, S, Fitzsimons, D, Garbi, M, Gevaert, S, Hindricks, G, Jondeau, G, Kluin, J, Lionis, C, McDonagh, TA, Meier, P, Moons, P, Pantazis, A, Piepoli, MF, Rocca, B, Roffi, M, Rosenkranz, S, Sarkozy, A, Shlyakhto, E, Silversides, CK, Sliwa, K, Sousa-Uva, M, Tamargo, J, Thorne, S, Van de Velde, M, Williams, B, Zamorano, JL, Windecker, S, Bueno, H, Collet, J-P, Dean, V, Gaemperli, O, Jüni, P, Katus, HA, Knuuti, J, Lancellotti, P, Leclercq, C, Ponikowski, P, Richter, DJ, Hammoudi, N, Piruzyan, A, Mascherbauer, J, Samadov, F, Prystrom, A, Pasquet, A, Caluk, J, Gotcheva, N, Skoric, B, Heracleous, H, Vejlstrup, N, Maser, M, Kaaja, RJ, Srbinovska-Kostovska, E, Mounier-Vehier, C, Vakhtangadze, T, Rybak, K, Giannakoulas, G, Kiss, RG, Thrainsdottir, IS, Erwin, RJ, Porter, A, Geraci, G, Ibrahimi, P, Lunegova, O, Mintale, I, Kadri, Z, Benlamin, H, Barysiene, J, Banu, CA, Caruana, M, Gratii, C, Haddour, L, Bouma, BJ, Estensen, M-E, Hoffman, P, Petris, AO, Moiseeva, O, Bertelli, L, Tesic, BV, Dubrava, J, Koželj, M, Prieto-Arévalo, R, Furenäs, E, Schwerzmann, M, Mourali, MS, Ozer, N, Mitchenko, O, Nelson-Piercy, C, Regitz-Zagrosek, V., Roos-Hesselink, J. W., Bauersachs, J., Blomstrom-Lundqvist, C., Cifkova, R., De Bonis, M., Iung, B., Johnson, M. R., Kintscher, U., Kranke, P., Lang, I. M., Morais, J., Pieper, P. G., Presbitero, P., Price, S., Rosano, G. M. C., Seeland, U., Simoncini, T., Swan, L., Warnes, C. A., Regitz-Zagrosek, Vera, Roos-Hesselink, Jolien W, Bauersachs, Johann, Blomström-Lundqvist, Carina, Cífková, Renata, De Bonis, Michele, Iung, Bernard, Johnson, Mark Richard, Kintscher, Ulrich, Kranke, Peter, Lang, Irene Marthe, Morais, Joao, Pieper, Petronella G, Presbitero, Patrizia, Price, Susanna, Rosano, Giuseppe MC, Seeland, Ute, Simoncini, Tommaso, Swan, Lorna, Warnes, Carole A, and Cardiology

Subjects
Counseling, Prenatal Diagnosi, 030204 cardiovascular system & hematology, Guideline, Cardiovascular, 0302 clinical medicine, Pregnancy, Prenatal Diagnosis, 030212 general & internal medicine, 1102 Cardiorespiratory Medicine and Haematology, Societies, Medical, Risk assessment, Advisory Committee, Advisory Committees, Cardiology, Cardiovascular Agents, Europe, Female, Humans, Poland, Pregnancy Complications, Cardiovascular, Practice Guidelines as Topic, valvular heart disease, Cardiovascular disease, Management, Hypertension, Drug therapy, Cardiology and Cardiovascular Medicine, Arrhythmia, Human, medicine.medical_specialty, Settore BIO/14 - FARMACOLOGIA, Cardiomyopathy, Heart failure, Cardiovascular therapy, Pulmonary hypertension, Aortic pathology, 03 medical and health sciences, SDG 3 - Good Health and Well-being, Medical, medicine, Cardiovascular diagnosis, Intensive care medicine, Congenital heart disease, Pharmacology, business.industry, ta3121, medicine.disease, Valvular heart disease, Pregnancy Complications, Cardiovascular System & Hematology, Cardiovascular Agent, Societies, business
Published
2019

37. Assessment of myocardial perfusion by dynamic O-15-labeled water PET imaging: Validation of a new fast factor analysis

Author

Adachi, I, Gaemperli, O, Valenta, I, Schepis, T, Siegrist, P T, Treyer, V, Burger, C, Morita, K, Kaufmann, P A, University of Zurich, and Kaufmann, P A

Subjects
10076 Center for Integrative Human Physiology, 570 Life sciences, biology, 2741 Radiology, Nuclear Medicine and Imaging, 610 Medicine & health, 10181 Clinic for Nuclear Medicine, 2705 Cardiology and Cardiovascular Medicine
Abstract

Background: Factor analysis (FA) is an established method for separating myocardium from blood pool by use of oxygen 15-labeled water and positron emission tomography for analyzing myocardial blood flow (MBF). Conventional FA methods generating images from sinograms (sinoFA) are time-consuming, whereas FA can be performed on the reconstructed images (reconFA) in a fraction of time. We validated the MBF values obtained by reconFA versus sinoFA. Methods and Results: In 23 volunteers (mean age, 26.6±3.4 years) MBF was calculated from sinoFA and reconFA and blindly reanalyzed 1 month later by the same observer. Intraobserver agreement and reconFA-versus-sinoFA agreement were assessed according to Bland and Altman (BA). Reproducibility proved excellent for global sinoFA (r=0.968; P

Published
2018

38. 11Coronary Computed Tomography angiography-derived endothelial shear stress in myocardial bridging -a descriptive study-

Author

Giannopoulos, A, primary, Bolt, B B, additional, Benz, D B, additional, Messerli, M M, additional, Schwyzer, M S, additional, Von Felten, E V F, additional, Kamani, K C, additional, Patriki, D P, additional, Gebhard, C G, additional, Pazhenkottil, A P P, additional, Graeni, C G, additional, Kaufmann, P A K, additional, Buechel, R R B, additional, and Gaemperli, O G, additional

Published
2019
Full Text
View/download PDF

39. 359Characterization of functionally significant coronary artery disease by a computed tomography coronary angiography (CTCA) based index: a comparison with SPECT

Author

Pitsargiotis, T, primary, Neglia, D, additional, Siogkas, P K, additional, Benetos, G, additional, Liga, R, additional, Sakellarios, A I, additional, Maaniitty, T, additional, Scholte, A, additional, Gaemperli, O, additional, Kaufmann, P A, additional, Pelosi, G, additional, Parodi, O, additional, Reyes, E, additional, Fotiadis, D I, additional, and Anagnostopoulos, C D, additional

Published
2019
Full Text
View/download PDF

40. 2016 European Guidelines on cardiovascular disease prevention in clinical practice The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

Author

Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FDR, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WMM1, Binno S, De Backer G, Roffi M, Aboyans V, Bachl N, Bueno H, Carerj S, Cho L, Cox J, De Sutter J, Egidi G, Fisher M, Fitzsimons D, Franco OH, Guenoun M, Jennings C, Jug B, Kirchhof P, Kotseva K, Lip GY, Mach F, Mancia G, Bermudo FM, Mezzani A, Niessner A, Ponikowski P, Rauch B, Rydén L, Stauder A, Turc G, Wiklund O, Windecker S, Zamorano JL, Achenbach S, Badimon L, Barón-Esquivias G, Baumgartner H, Bax JJ, Dean V, Erol Ç, Gaemperli O, Kolh P, Lancellotti P, Nihoyannopoulos P, Torbicki A, Vaz Carneiro A, Metzler B, Najafov R, Stelmashok V, De Maeyer C, Dilic M, Gruev I, Milicic D, Vaverkova H, Gustafsson I, Attia I, Duishvili D, Kostova N, Ferrières J, Klimiashvili Z, Hambrecht R, Tsioufis K, Szabados E, Andersen K, Vaughan C, Zafrir B, Novo S, Davletov K, Jashari F, Kerimkulova A, Mintale I, Saade G, Petrulioniene Z, Delagardelle C, Magri CJ, Rudi V, Oukerraj L, Çölkesen BE, Schirmer H, Jankowski P, Dos Reis RP, Gherasim D, Nedogoda S, Zavatta M, Giga V, Filipova S, Padial LR, Kiessling A, Mahdhaoui A, Ural D, Nesukay E, Gale C., Internal medicine, ICaR - Circulation and metabolism, Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FDR, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WMM1, Binno S, De Backer G, Roffi M, Aboyans V, Bachl N, Bueno H, Carerj S, Cho L, Cox J, De Sutter J, Egidi G, Fisher M, Fitzsimons D, Franco OH, Guenoun M, Jennings C, Jug B, Kirchhof P, Kotseva K, Lip GY, Mach F, Mancia G, Bermudo FM, Mezzani A, Niessner A, Ponikowski P, Rauch B, Rydén L, Stauder A, Turc G, Wiklund O, Windecker S, Zamorano JL, Zamorano JL, Aboyans V, Achenbach S, Agewall S, Badimon L, Barón-Esquivias G, Baumgartner H, Bax JJ, Bueno H, Carerj S, Dean V, Erol Ç, Fitzsimons D, Gaemperli O, Kirchhof P, Kolh P, Lancellotti P, Lip GY, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Roffi M, Torbicki A, Vaz Carneiro A, Windecker S, Metzler B, Najafov R, Stelmashok V, De Maeyer C, Dilic M, Gruev I, Milicic D, Vaverkova H, Gustafsson I, Attia I, Duishvili D, Kostova N, Ferrières J, Klimiashvili Z, Hambrecht R, Tsioufis K, Szabados E, Andersen K, Vaughan C, Zafrir B, Novo S, Davletov K, Jashari F, Kerimkulova A, Mintale I, Saade G, Petrulioniene Z, Delagardelle C, Magri CJ, Rudi V, Oukerraj L, Çölkesen BE, Schirmer H, Jankowski P, Dos Reis RP, Gherasim D, Nedogoda S, Zavatta M, Giga V, Filipova S, Padial LR, Kiessling A, Mach F, Mahdhaoui A, Ural D, Nesukay E, Gale C., Cardio-vascular diseases, and Clinical sciences

Subjects
Cost-Benefit Analysis, General Practice, 030204 cardiovascular system & hematology, Guideline, Diabete, 0302 clinical medicine, Hyperlipidemia, Stakeholder, Medicine, 030212 general & internal medicine, Multiple Chronic Conditions, Practice Patterns, Physicians', Societies, Medical, Risk assessment, education.field_of_study, Cardiac Rehabilitation, Diabetes, Rehabilitation, Smoking, Psychosocial factor, Age Factors, Lipid, Middle Aged, Primary care, Pedigree, Europe, Cardiovascular Diseases, Psychosocial factors, Hypertension, Blood pressure, Diet, Healthy, Cardiology and Cardiovascular Medicine, Adult, Diagnostic Imaging, medicine.medical_specialty, Ambulatory blood pressure, Population, Cardiology, Healthy lifestyle, Hyperlipidemias, Health Promotion, Diabetic angiopathy, Guidelines, Risk Assessment, 03 medical and health sciences, Sex Factors, Diabetes mellitus, Journal Article, Humans, Clinical settings, Healthy Lifestyle, Intensive care medicine, education, Exercise, Antihypertensive Agents, Nutrition, Aged, business.industry, Vascular disease, Physical activity, Prevention, medicine.disease, body regions, Clinical setting, Risk management, Socioeconomic Factors, Smoking Cessation, Joint Esc Guidelines, business, Biomarkers, Diabetic Angiopathies
Abstract

ABI : ankle–brachial (blood pressure) index ABPM : ambulatory blood pressure monitoring ACCORD : Action to Control Cardiovascular Risk in Diabetes ACE-I : angiotensin-converting enzyme inhibitor ACS : acute coronary syndromes ADVANCE : Action in Diabetes and Vascular disease: PreterAx

Published
2016

41. 2016 European Guidelines on cardiovascular disease prevention in clinical practice

Author

Piepoli, MF, Hoes, AW, Agewall, S, Albus, C, Brotons, C, Catapano, AL, Cooney, MT, Corrà, U, Cosyns, B, Deaton, C, Graham, I, Hall, MS, Hobbs, FDR, Løchen, ML, Löllgen, H, Marques-Vidal, P, Perk, J, Prescott, E, Redon, J, Richter, DJ, Sattar, N, Smulders, Y, Tiberi, M, Van Der Worp, HB, Van Dis, I, Verschuren, WM M, Binno, S, De Backer, G, Roffi, M, Aboyans, V, Bachl, N, Carerj, S, Cho, Le, Cox, J, De Sutter, J, Egidi, G, Fisher, M, Fitzsimons, D, Franco, OH, Guenoun, M, Jennings, C, Jug, B, Kirchhof, P, Kotseva, K, Lip, GYH, Mach, F, Mancia, G, Bermudo, FM, Mezzani, A, Niessner, A, Ponikowski, P, Rauch, B, Stauder, A, Turc, G, Wiklund, O, Windecker, S, Zamorano, JL, Achenbach, S, Badimon, L, Barón-Esquivias, G, Baumgartner, H, Bax, JJ, Dean, V, Erol, Ç, Gaemperli, O, Kolh, P, Lancellotti, P, Nihoyannopoulos, P, Torbicki, A, Carneiro, AV, Metzler, B, Najafov, R, Stelmashok, V, De Maeyer, C, Dilić, M, Gruev, I, Miličić, D, Vaverkova, H, Gustafsson, I, Attia, I, Duishvili, D, Ferrières, J, Kostova, N, Klimiashvili, Z, Hambrecht, R, Tsioufis, K, Szabados, E, Andersen, K, Vaughan, C, Zafrir, B, Novo, S, Davletov, K, Jashari, F, Kerimkulova, A, Mintale, I, Saade, G, Petrulioniene, Z, Delagardelle, C, Magri, CJ, Rudi, V, Oukerraj, L, Çölkesen, BE, Schirmer, H, Dos Reis, RP, Gherasim, D, Nedogoda, S, Zavatta, M, Giga, V, Filipova, S, Padial, LR, Kiessling, A, Mahdhaoui, A, Ural, D, Nesukay, E, Gale, C, Piepoli, M, Hoes, A, Agewall, S, Albus, C, Brotons, C, Catapano, A, Cooney, M, Corrà, U, Cosyns, B, Deaton, C, Graham, I, Hall, M, Hobbs, F, Løchen, M, Löllgen, H, Marques-Vidal, P, Perk, J, Prescott, E, Redon, J, Richter, D, Sattar, N, Smulders, Y, Tiberi, M, Van Der Worp, H, Van Dis, I, Verschuren, W, Binno, S, De Backer, G, Roffi, M, Aboyans, V, Bachl, N, Carerj, S, Cho, L, Cox, J, De Sutter, J, Egidi, G, Fisher, M, Fitzsimons, D, Franco, O, Guenoun, M, Jennings, C, Jug, B, Kirchhof, P, Kotseva, K, Lip, G, Mach, F, Mancia, G, Bermudo, F, Mezzani, A, Niessner, A, Ponikowski, P, Rauch, B, Stauder, A, Turc, G, Wiklund, O, Windecker, S, Zamorano, J, Achenbach, S, Badimon, L, Barón-Esquivias, G, Baumgartner, H, Bax, J, Dean, V, Erol, Ç, Gaemperli, O, Kolh, P, Lancellotti, P, Nihoyannopoulos, P, Torbicki, A, Carneiro, A, Metzler, B, Najafov, R, Stelmashok, V, De Maeyer, C, Dilić, M, Gruev, I, Miličić, D, Vaverkova, H, Gustafsson, I, Attia, I, Duishvili, D, Ferrières, J, Kostova, N, Klimiashvili, Z, Hambrecht, R, Tsioufis, K, Szabados, E, Andersen, K, Vaughan, C, Zafrir, B, Novo, S, Davletov, K, Jashari, F, Kerimkulova, A, Mintale, I, Saade, G, Petrulioniene, Z, Delagardelle, C, Magri, C, Rudi, V, Oukerraj, L, Çölkesen, B, Schirmer, H, Dos Reis, R, Gherasim, D, Nedogoda, S, Zavatta, M, Giga, V, Filipova, S, Padial, L, Kiessling, A, Mahdhaoui, A, Ural, D, Nesukay, E, and Gale, C

Subjects
Adult, Diagnostic Imaging, Diabetic Angiopathie, Healthy Diet, General Practice, Population, Healthy lifestyle, Health Promotion, Sex Factor, Guideline, Guidelines, Diabete, Socioeconomic Factor, Blood pressure, Clinical settings, Diabetes, Lipid, Nutrition, Physical activity, Prevention, Primary care, Psychosocial factors, Rehabilitation, Risk assessment, Risk management, Smoking, Stakeholder, Cardiology and Cardiovascular Medicine, Cardiovascular Disease, Age Factor, Cost-Benefit Analysi, Practice Patterns, Physicians', Exercise, Aged, Cardiac Rehabilitation, Psychosocial factor, Biomarker, Middle Aged, Multiple Chronic Condition, Pedigree, Clinical setting, Antihypertensive Agent, Hyperlipidemia, Hypertension, Smoking Cessation, Human
Published
2016

46. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

Author

Valgimigli, M., Bueno, H., Byrne, R. A., Collet, J. -P., Costa, F., Jeppsson, A., Kastrati, A., Kolh, P., Mauri, L., Montalescot, G., Neumann, F. -J., Petricevic, M., Roffi, M., Steg, P. G., Zamorano, J. L., Levine, G. N., Badimon, L., Vranckx, P., Agewall, S., Andreotti, Felicita, Antman, E., Barbato, E., Bassand, J. -P., Bugiardini, R., Cikirikcioglu, M., Cuisset, T., De Bonis, M., Delgado, V., Fitzsimons, D., Galie, N., Gilard, M., Hamm, C. W., Ibanez, B., James, S., Knuuti, J., Landmesser, U., Leclercq, C., Lettino, M., Lip, G., Piepoli, M. F., Pierard, L., Schwerzmann, M., Sechtem, U., Simpson, I. A., Uva, M. S., Stabile, E., Storey, R. F., Tendera, M., Van De Werf, F., Verheugt, F., Aboyans, V., Windecker, S., Coca, A., Coman, I. M., Dean, V., Gaemperli, O., Hindricks, G., Iung, B., Juni, P., Katus, H. A., Lancellotti, P., Mcdonagh, T., Ponikowski, P., Richter, D. J., Shlyakhto, E., Roithinger, F. X., Aliyev, F., Stelmashok, V., Desmet, W., Postadzhiyan, A., Georghiou, G. P., Motovska, Z., Grove, E. L., Marandi, T., Kiviniemi, T., Kedev, S., Massberg, S., Alexopoulos, D., Kiss, R. G., Gudmundsdottir, I. J., Mcfadden, E. P., Lev, E., De Luca, L., Sugraliyev, A., Haliti, E., Mirrakhimov, E., Latkovskis, G., Petrauskiene, B., Huijnen, S., Magri, C. J., Cherradi, R., Ten Berg, J. M., Eritsland, J., Budaj, A., Aguiar, C. T., Duplyakov, D., Zavatta, M., Antonijevic, N. M., Fras, Z., Montoliu, A. T., Varenhorst, C., Tsakiris, D., Addad, F., Aydogdu, S., Parkhomenko, A., Kinnaird, T., Andreotti F. (ORCID:0000-0002-1456-6430), Valgimigli, M., Bueno, H., Byrne, R. A., Collet, J. -P., Costa, F., Jeppsson, A., Kastrati, A., Kolh, P., Mauri, L., Montalescot, G., Neumann, F. -J., Petricevic, M., Roffi, M., Steg, P. G., Zamorano, J. L., Levine, G. N., Badimon, L., Vranckx, P., Agewall, S., Andreotti, Felicita, Antman, E., Barbato, E., Bassand, J. -P., Bugiardini, R., Cikirikcioglu, M., Cuisset, T., De Bonis, M., Delgado, V., Fitzsimons, D., Galie, N., Gilard, M., Hamm, C. W., Ibanez, B., James, S., Knuuti, J., Landmesser, U., Leclercq, C., Lettino, M., Lip, G., Piepoli, M. F., Pierard, L., Schwerzmann, M., Sechtem, U., Simpson, I. A., Uva, M. S., Stabile, E., Storey, R. F., Tendera, M., Van De Werf, F., Verheugt, F., Aboyans, V., Windecker, S., Coca, A., Coman, I. M., Dean, V., Gaemperli, O., Hindricks, G., Iung, B., Juni, P., Katus, H. A., Lancellotti, P., Mcdonagh, T., Ponikowski, P., Richter, D. J., Shlyakhto, E., Roithinger, F. X., Aliyev, F., Stelmashok, V., Desmet, W., Postadzhiyan, A., Georghiou, G. P., Motovska, Z., Grove, E. L., Marandi, T., Kiviniemi, T., Kedev, S., Massberg, S., Alexopoulos, D., Kiss, R. G., Gudmundsdottir, I. J., Mcfadden, E. P., Lev, E., De Luca, L., Sugraliyev, A., Haliti, E., Mirrakhimov, E., Latkovskis, G., Petrauskiene, B., Huijnen, S., Magri, C. J., Cherradi, R., Ten Berg, J. M., Eritsland, J., Budaj, A., Aguiar, C. T., Duplyakov, D., Zavatta, M., Antonijevic, N. M., Fras, Z., Montoliu, A. T., Varenhorst, C., Tsakiris, D., Addad, F., Aydogdu, S., Parkhomenko, A., Kinnaird, T., and Andreotti F. (ORCID:0000-0002-1456-6430)

Abstract

N/A

Published
2018

47. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy

Author

Deaton, C, Simpson, Ia, Aboyans, V, Agewall, S, Barbato, E, Calda, P, Coca, A, Coman, Im, De Backer, J, Delgado, V, Di Salvo, G, Fitzsimmons, S, Fitzsimons, D, Garbi, M, Gevaert, S, Hindricks, G, Jondeau, G, Kluin, J, Lionis, C, Mcdonagh, Ta, Meier, P, Moons, P, Pantazis, A, Piepoli, Mf, Rocca, Bianca, Roffi, M, Rosenkranz, S, Sarkozy, A, Shlyakhto, E, Silversides, Ck, Sliwa, K, Sousa-Uva, M, Tamargo, J, Thorne, S, Van de Velde, M, Williams, B, Zamorano, Jl, Windecker, S, Bueno, H, Collet, Jp, Dean, V, Gaemperli, O, Iung, B, Jüni, P, Katus, Ha, Knuuti, J, Lancellotti, P, Leclercq, C, Ponikowski, P, Richter, Dj, Hammoudi, N, Piruzyan, A, Mascherbauer, J, Samadov, F, Prystrom, A, Pasquet, A, Caluk, J, Gotcheva, N, Skoric, B, Heracleous, H, Vejlstrup, N, Maser, M, Kaaja, Rj, Srbinovska-Kostovska, E, Mounier-Vehier, C, Vakhtangadze, T, Rybak, K, Giannakoulas, G, Kiss, Rg, Thrainsdottir, I, Erwin, Rj, Porter, A, Geraci, G, Ibrahimi, P, Lunegova, O, Mintale, I, Kadri, Z, Benlamin, H, Barysiene, J, Banu, Ca, Caruana, M, Gratii, C, Haddour, L, Bouma, Bj, Estensen, Me, Hoffman, P, Petris, Ao, Moiseeva, O, Bertelli, L, Tesic, Bv, Dubrava, J, Koželj, M, Prieto-Arévalo, R, Furenäs, E, Schwerzmann, M, Mourali, M, Ozer, N, Mitchenko, O, Nelson-Piercy, C., Rocca B (ORCID:0000-0001-8304-6423), Deaton, C, Simpson, Ia, Aboyans, V, Agewall, S, Barbato, E, Calda, P, Coca, A, Coman, Im, De Backer, J, Delgado, V, Di Salvo, G, Fitzsimmons, S, Fitzsimons, D, Garbi, M, Gevaert, S, Hindricks, G, Jondeau, G, Kluin, J, Lionis, C, Mcdonagh, Ta, Meier, P, Moons, P, Pantazis, A, Piepoli, Mf, Rocca, Bianca, Roffi, M, Rosenkranz, S, Sarkozy, A, Shlyakhto, E, Silversides, Ck, Sliwa, K, Sousa-Uva, M, Tamargo, J, Thorne, S, Van de Velde, M, Williams, B, Zamorano, Jl, Windecker, S, Bueno, H, Collet, Jp, Dean, V, Gaemperli, O, Iung, B, Jüni, P, Katus, Ha, Knuuti, J, Lancellotti, P, Leclercq, C, Ponikowski, P, Richter, Dj, Hammoudi, N, Piruzyan, A, Mascherbauer, J, Samadov, F, Prystrom, A, Pasquet, A, Caluk, J, Gotcheva, N, Skoric, B, Heracleous, H, Vejlstrup, N, Maser, M, Kaaja, Rj, Srbinovska-Kostovska, E, Mounier-Vehier, C, Vakhtangadze, T, Rybak, K, Giannakoulas, G, Kiss, Rg, Thrainsdottir, I, Erwin, Rj, Porter, A, Geraci, G, Ibrahimi, P, Lunegova, O, Mintale, I, Kadri, Z, Benlamin, H, Barysiene, J, Banu, Ca, Caruana, M, Gratii, C, Haddour, L, Bouma, Bj, Estensen, Me, Hoffman, P, Petris, Ao, Moiseeva, O, Bertelli, L, Tesic, Bv, Dubrava, J, Koželj, M, Prieto-Arévalo, R, Furenäs, E, Schwerzmann, M, Mourali, M, Ozer, N, Mitchenko, O, Nelson-Piercy, C., and Rocca B (ORCID:0000-0001-8304-6423)

Abstract

Guidelines summarize and evaluate available evidence with the aim of assisting health professionals in selecting the best management strategies for an individual patient with a given condition. Guidelines and their recommendations should facilitate decision making of health professionals in their daily practice. However, the final decisions concerning an individual patient must be made by the responsible health professional(s) in consultation with the patient and caregiver as appropriate.

Published
2018

48. 3 - Single-photon emission computed tomography

Author

Nieman, K, Gaemperli, O, Lancellotti, P, Plein, S, Nieman, K ( K ), Gaemperli, O ( O ), Lancellotti, P ( P ), Plein, S ( S ), Buechel, R R, Kaufmann, P A, Nieman, K, Gaemperli, O, Lancellotti, P, Plein, S, Nieman, K ( K ), Gaemperli, O ( O ), Lancellotti, P ( P ), Plein, S ( S ), Buechel, R R, and Kaufmann, P A

Published
2015

49. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases

Author

Adler, Y, Charron, P, Imazio, M, Badano, L, Baron-Esquivias, G, Bogaert, J, Brucato, A, Gueret, P, Klingel, K, Lionis, C, Maisch, B, Mayosi, B, Pavie, A, Ristic, A, Tenas, M, Seferovic, P, Swedberg, K, Tomkowski, W, Achenbach, S, Agewall, S, Al-Attar, N, Ferrer, J, Arad, M, Asteggiano, R, Bueno, H, Caforio, A, Carerj, S, Ceconi, C, Evangelista, A, Flachskampf, F, Giannakoulas, G, Gielen, S, Habib, G, Kolh, P, Lambrinou, E, Lancellotti, P, Lazaros, G, Linhart, A, Meurin, P, Nieman, K, Piepoli, M, Price, S, Roos-Hesselink, J, Zamorano, J, Aboyans, V, Badimon, L, Baumgartner, H, Bax, J, Dean, V, Erol, C, Fitzimons, D, Gaemperli, O, Kirchhof, P, Lip, G, Nihoyannopoulos, P, Ponikowski, P, Roffi, M, Torbicki, A, Carneiro, A, Windecker, S, Adler Y., Charron P., Imazio M., Badano L., Baron-Esquivias G., Bogaert J., Brucato A., Gueret P., Klingel K., Lionis C., Maisch B., Mayosi B., Pavie A., Ristic A. D., Tenas M. S., Seferovic P., Swedberg K., Tomkowski W., Achenbach S., Agewall S., Al-Attar N., Ferrer J. A., Arad M., Asteggiano R., Bueno H., Caforio A. L. P., Carerj S., Ceconi C., Evangelista A., Flachskampf F., Giannakoulas G., Gielen S., Habib G., Kolh P., Lambrinou E., Lancellotti P., Lazaros G., Linhart A., Meurin P., Nieman K., Piepoli M. F., Price S., Roos-Hesselink J., Zamorano J. L., Aboyans V., Badimon L., Baumgartner H., Bax J. J., Dean V., Erol C., Fitzimons D., Gaemperli O., Kirchhof P., Lip G. Y. H., Nihoyannopoulos P., Ponikowski P., Roffi M., Torbicki A., Carneiro A. V., Windecker S., Adler, Y, Charron, P, Imazio, M, Badano, L, Baron-Esquivias, G, Bogaert, J, Brucato, A, Gueret, P, Klingel, K, Lionis, C, Maisch, B, Mayosi, B, Pavie, A, Ristic, A, Tenas, M, Seferovic, P, Swedberg, K, Tomkowski, W, Achenbach, S, Agewall, S, Al-Attar, N, Ferrer, J, Arad, M, Asteggiano, R, Bueno, H, Caforio, A, Carerj, S, Ceconi, C, Evangelista, A, Flachskampf, F, Giannakoulas, G, Gielen, S, Habib, G, Kolh, P, Lambrinou, E, Lancellotti, P, Lazaros, G, Linhart, A, Meurin, P, Nieman, K, Piepoli, M, Price, S, Roos-Hesselink, J, Zamorano, J, Aboyans, V, Badimon, L, Baumgartner, H, Bax, J, Dean, V, Erol, C, Fitzimons, D, Gaemperli, O, Kirchhof, P, Lip, G, Nihoyannopoulos, P, Ponikowski, P, Roffi, M, Torbicki, A, Carneiro, A, Windecker, S, Adler Y., Charron P., Imazio M., Badano L., Baron-Esquivias G., Bogaert J., Brucato A., Gueret P., Klingel K., Lionis C., Maisch B., Mayosi B., Pavie A., Ristic A. D., Tenas M. S., Seferovic P., Swedberg K., Tomkowski W., Achenbach S., Agewall S., Al-Attar N., Ferrer J. A., Arad M., Asteggiano R., Bueno H., Caforio A. L. P., Carerj S., Ceconi C., Evangelista A., Flachskampf F., Giannakoulas G., Gielen S., Habib G., Kolh P., Lambrinou E., Lancellotti P., Lazaros G., Linhart A., Meurin P., Nieman K., Piepoli M. F., Price S., Roos-Hesselink J., Zamorano J. L., Aboyans V., Badimon L., Baumgartner H., Bax J. J., Dean V., Erol C., Fitzimons D., Gaemperli O., Kirchhof P., Lip G. Y. H., Nihoyannopoulos P., Ponikowski P., Roffi M., Torbicki A., Carneiro A. V., and Windecker S.

Published
2015

50. ESC 2017 guidelines on the treatment of acute myocardial infarction in patients with ST segment elevation

Author

Ibanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., Caforio, A. L. P., Crea, F., Goudevenos, J. A., Halvorsen, S., Hindricks, G., Kastrati, A., Lenzen, M. J., Prescott, E., Roffi, M., Valgimigli, M., Varenhorst, C., Vranckx, P., Widimsk, P., Collet, J. -P., Kristensen, S. D., Aboyans, V., Baumbach, A., Bugiardini, R., Mircea Coman, I., Delgado, V., Fitzsimons, D., Gaemperli, O., Gershlick, A. H., Gielen, S., Harjola, V. -P., Katus, H. A., Knuuti, J., Kolh, P., Leclercq, C., Lip, G. Y. H., MORAIS FRAGA, JOANA SOFIA, Neskovic, A. N., Neumann, F. -J., Niessner, A., Piepoli, M. F., Richter, D. J., Shlyakhto, E., Simpson, I. A., Steg, G., Terkelsen, C. J., Thygesen, K., Windecker, S., Zamorano, J. L., and Zeymer, U.

Published
2017

Catalog

Books, media, physical & digital resources
See catalog results